Literature DB >> 11744728

Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants.

Yi-Hung Chen1, Annie P-C Chen, Chao-Tsen Chen, Andrew H-J Wang, Po-Huang Liang.   

Abstract

Undecaprenyl pyrophosphate synthase (UPPS) catalyzes the consecutive condensation reactions of eight isopentenyl pyrophosphate (IPP) with farnesyl pyrophosphate (FPP) to generate C(55) undecaprenyl pyrophosphate (UPP). In the present study, site-directed mutagenesis, fluorescence quenching, and stopped-flow methods were utilized to examine the substrate binding and the protein conformational change. (S)-Farnesyl thiopyrophosphate (FsPP), a FPP analogue, was synthesized to probe the enzyme inhibition and events associated with the protein fluorescence change. This compound with a much less labile thiopyrophosphate shows K(i) value of 0.2 microm in the inhibition of Escherichia coli UPPS and serves as a poor substrate, with the k(cat) value (3.1 x 10(-7) s(-1)) 10(7) times smaller than using FPP as the substrate. Reduction of protein intrinsic fluorescence was observed upon addition of FPP (or FsPP) to the UPPS solution. Moreover, fluorescence studies carried out using W91F and other mutant UPPS with Trp replaced by Phe indicate that FPP binding mainly quenches the fluorescence of Trp-91, a residue in the alpha3 helix that moves toward the active site during substrate binding. Using stopped-flow apparatus, a three-phase protein fluorescence change with time was observed by mixing the E.FPP complex with IPP in the presence of Mg(2+). However, during the binding of E.FsPP with IPP, only the fastest phase was observed. These results suggest that the first phase is due to the IPP binding to E.FPP complex, and the other two slow phases are originated from the protein conformational change. The two slow phases coincide with the time course of FPP chain elongation from C(15) to C(55) and product release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744728     DOI: 10.1074/jbc.M110014200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  cis-Prenyltransferase: New Insights into Protein Glycosylation, Rubber Synthesis, and Human Diseases.

Authors:  Kariona A Grabińska; Eon Joo Park; William C Sessa
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

2.  A Defective Undecaprenyl Pyrophosphate Synthase Induces Growth and Morphological Defects That Are Suppressed by Mutations in the Isoprenoid Pathway of Escherichia coli.

Authors:  William J MacCain; Suresh Kannan; Dannah Z Jameel; Jerry M Troutman; Kevin D Young
Journal:  J Bacteriol       Date:  2018-08-24       Impact factor: 3.490

3.  Undecaprenyl pyrophosphate involvement in susceptibility of Bacillus subtilis to rare earth elements.

Authors:  Takashi Inaoka; Kozo Ochi
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

4.  Substrate and product specificities of cis-type undecaprenyl pyrophosphate synthase.

Authors:  Annie P-C Chen; Sing-Yang Chang; Yu-Chung Lin; Yang-Sheng Sun; Chao-Tsen Chen; Andrew H-J Wang; Po-Huang Liang
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

5.  Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.

Authors:  Lac V Lee; Brian Granda; Karl Dean; Jianshi Tao; Eugene Liu; Rui Zhang; Stefan Peukert; Sompong Wattanasin; Xiaoling Xie; Neil S Ryder; Ruben Tommasi; Gejing Deng
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

6.  Synthesis and NMR characterization of (Z,Z,Z,Z,E,E,ω)-heptaprenol.

Authors:  Dusan Hesek; Mijoon Lee; Jaroslav Zajíček; Jed F Fisher; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2012-08-10       Impact factor: 15.419

7.  Substrate binding mode and reaction mechanism of undecaprenyl pyrophosphate synthase deduced from crystallographic studies.

Authors:  Sing-Yang Chang; Tzu-Ping Ko; Annie P-C Chen; Andrew H-J Wang; Po-Huang Liang
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

8.  Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication.

Authors:  Chih-Chun Wen; Lie-Fen Shyur; Jia-Tsrong Jan; Po-Huang Liang; Chih-Jung Kuo; Palanisamy Arulselvan; Jin-Bin Wu; Sheng-Chu Kuo; Ning-Sun Yang
Journal:  J Tradit Complement Med       Date:  2011-10

Review 9.  A Perspective on Emerging Therapeutic Interventions for COVID-19.

Authors:  Muhammad Torequl Islam; Md Nasiruddin; Ishaq N Khan; Siddhartha Kumar Mishra; Md Kudrat-E-Zahan; Thoufiqul Alam Riaz; Eunus S Ali; M Safiur Rahman; Mohammad S Mubarak; Miquel Martorell; William C Cho; Daniela Calina; Anca Oana Docea; Javad Sharifi-Rad
Journal:  Front Public Health       Date:  2020-07-03

10.  Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.

Authors:  Chih-Jung Kuo; Ya-Hui Chi; John T-A Hsu; Po-Huang Liang
Journal:  Biochem Biophys Res Commun       Date:  2004-06-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.